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ABSTRACT 
In addition to its stimulatory effect, caffeine has been also associated with 
suppressing lipid accumulation and weight gain, making the well established energy 
drink market an ideal avenue to expand product health functionality.  The objective of 
this study was to evaluate the effect of caffeine extracted from Yerba mate (Ilex 
paraguariensis) (matein, MT) and green coffee (Coffea arabica) byproducts (fractions 
GC1, GC2, GC3 and GC4) on inhibition of lipid accumulation in 3T3-L1 adipocytes 
compared to synthetic caffeine (SC).   The antioxidant capacity (AC) and total 
polyphenol content (TPC) of these novel caffeine sources were also investigated and 
compared to SC using the Oxygen Radical Absorbance (ORAC) assay and the Folin-
Ciocalteu method, respectively.  Lipid quantification was done by the Oil Red O staining 
and real time polymerase chain reaction (RT-PCR) was performed to determine 
expression of two genes involved in lipid metabolism, lipoprotein lipase (LPL) and fatty 
acid synthase (FAS).  Inhibition of lipid accumulation (%) was highly correlated to 
caffeine concentration of the samples (R2 = 0.88).  MT and GC1 had the highest caffeine 
concentrations (90.8 and 93.8%, respectively), and exhibited the highest lipid reduction 
(18.3 and 17.1%, respectively) compared to untreated cells (p<0.05).  MT and GC1 had 
similar inhibition of lipid accumulation compared to SC (16.3%), epigallocatechin gallate 
(EGCG) (17.5%), and Orlistat (17.9%).  Adipocytes treated throughout differentiation 
resulted in an elevated inhibitory effect, with MT (22.8 ± 2.2%) and GC1 (26.8 ± 1.8%) 
having similar inhibitory capacity to SC (29.3 ± 0.5%).  RT-PCR showed MT and GC1 
may play a role in lipid metabolism by suppressing LPL and FAS.  The GC byproducts 
and MT at 1000 µM had an AC range of 19.4 ± 0.2 to 1550.2 ± 19.2 with a mean of 
446.5 Trolox µM equivalents (eq.), whereas SC had none.  The TPC of the GC 
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byproducts, MT, and SC ranged from 5.7 ± 0.3 to 153.5 ± 1.1 gallic acid (GA) µg eq., 
with SC resulting in the lowest.  In conclusion, these results suggest that the 
incorporation of MT and GC1 into beverage formulations would provide a natural source 
of caffeine and potentially aid in long-term weight maintenance, and give in contrast to 
SC, antioxidant benefits. 
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I. INTRODUCTION 
 Obesity is characterized by a chronic imbalance between energy intake and 
energy expenditure resulting in an enlargement in adipose tissue due to an increase in 
both adipocyte cell number (hyperplasia) and size (hypertrophy) (Schmid and others, 
2005; Avram and others, 2007; Bays and others, 2008).  Its prevalence has steadily 
increased worldwide and is one of the leading causes of preventable deaths due to its 
association with the development of a number of diseases including type II diabetes, 
coronary heart disease, hypertension and a heightened incidence of certain forms of 
cancer (Kopelman, 2000; Zimmet and Alberti, 2008).  The amount of adipose tissue can 
be regulated through the inhibition of adipogenesis and fat accumulation (Rayalam and 
others, 2008).  Fat accumulation in adipose tissue can be reduced by reducing lipid 
uptake by adipocytes through the suppression of lipoprotein lipase (LPL) or reducing 
lipid synthesis through inhibiting fatty acid synthase (FAS) among other mechanisms 
(Jing-Jing and others, 2008; Wang and Eckel, 2009).  Increased research in the area of 
bioactive compounds and their potential role for the improvement of long term weight 
maintenance are needed.  Weight loss is increasingly recognized to have major health 
benefits for overweight individuals as well as increase the life expectancy of those 
suffering from obesity-related health complications (Goldstein, 1992; Westerterp-
Plantenga and others, 2005; Rayman and others, 2008).  It has been found that modest 
weight loss of just 5% to 10% of initial body weight can lead to beneficial health effects 
(Goldstein, 1992; Wing and others, 1992; van Gaal and others, 1997).   
 Yerba mate (Ilex paraguariensis) tea is rich in caffeine and polyphenols, and 
has been associated with weight loss as well as also having a hypolipidemic effect 
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(Anderson and Fogh, 2001; Martins and others, 2009).  Similarly, studies have shown 
that coffee bean extracts can aid in weight management and have potent anti-obesity and 
hypotriglyceridemic properties due, in part, to its caffeine concentration (Tanaka and 
others, 2009).  Throughout coffee manufacturing, byproducts containing caffeine are 
produced which can be used as natural alternative sources to synthetic caffeine. 
Therefore, investigating the anti-obesity properties of natural caffeine sources would be 
beneficial to the food industry as well as the consumer.   
 Caffeine has been shown to have anti-obesity effects through the suppression of 
body weight gain and adipose tissue formation (Diepvens and others, 2007; Huang and 
others, 2009).  Caffeine has also been reported to suppress body weight gain by 
stimulating thermogenesis, extending sympathetic stimulation, suppressing food intake 
and reducing adipose tissue mass (Dulloo and others, 1999, 2000; Hasegawa and Mori, 
2000; Zheng and others, 2004; Kazuo and others, 2005; Kobayashi-Hattori and others, 
2005; Lopez-Garcia and others, 2006; Tanka and others, 2009). Thus, caffeine 
consumption could be an effective tool to increase the success rate of long-term weight 
maintenance and possible weight loss in humans.    
 The aim of this study was to evaluate in vitro the effect of caffeine, extracted 
from Yerba mate tea (matein, MT) and green coffee byproducts (fractions GC1, GC2, 
GC3 and GC4), on lipid accumulation, and FAS and LPL gene expression using 3T3-L1 
adipocytes, in comparison to synthetic caffeine (SC).  Furthermore, the antioxidant 
capacity (AC) and the total polyphenol content (TPC) of these natural sources of caffeine 
were analyzed and compared to SC.  The final objective was to replace SC in beverage 
applications with MT and GC byproducts.    
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II. LITERATURE REVIEW 
1.  Energy Drinks 
1.1 Market Size  
  Energy drinks fall into the category of functional beverages, which also 
encompasses sports drinks and nutraceutical beverages (Datamonitor, 2008).  Energy 
drinks refer to beverages that contain, besides calories, caffeine in combination with 
purportedly energy-enhancing ingredients such as taurine, herbal extracts, and B 
vitamins, with the advertised purpose of providing the consumer with increased energy.  
Energy drinks do not emphasize energy derived from the calories they contain, but rather 
through their caffeine or herbal supplement content.  Sports drinks are designed to be 
consumed before or during exercise to prevent dehydration, supply carbohydrates, and 
provide electrolytes and they typically do not contain caffeine (Coombes and Hamilton, 
2000).  Nutraceutical beverages on the other hand are designed to promote and enhance 
health, usually by containing bioactive compounds such as concentrated extracts from 
teas, fruits and vegetable or herbs.  Additionally, some nutraceutical beverages are 
fortified with vitamins and minerals and contain significant levels of antioxidants and 
polyphenols.  In some instances energy drinks could overlay into the nutraceutical 
beverage category depending on their ingredient composition.  The energy drink segment 
encompasses an array of options including ready-to-drink, shots and powder forms of the 
beverages.   
  Energy drinks first appeared in Europe and Asia in the 1960s in response to 
public demand for a dietary supplement that would result in increased energy (Reissig 
and others, 2009).  In 1962 a Japanese company, Taisho Pharmaceuticals, met that 
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demand by launching Lipovitan D, one of the very first energy drinks, which still 
dominates the Japanese market.  Lipovitan D contains B vitamins, taurine, and ginseng, 
which are all frequent constituents of mainstream energy drinks, with the intended 
purpose of providing the consumer with sustained energy to reduce mental and physical 
fatigue (Taisho Pharmaceutical Co. Ltd., 2009).  Energy drinks did not make their way 
into the U.S. market until 1997 when Red Bull was first introduced, which originated and 
was initially launched 10 years earlier in Austria (Reissig and others, 2009).  Since the 
1960’s, the energy drink market has grown into a multibillion dollar industry.  Globally, 
energy drinks hold 47.3% of the functional beverage’s overall market share, while in the 
U.S. energy drinks comprise 62.6% of this market share (Datamonitor, 2008).  Energy 
drinks in particular have seen impressive growth in the U.S., as well as abroad.  In 2008, 
the functional beverage industry reached global sales of $26.9 billion with a compound 
annual growth rate (CAGR) of 8.6% from 2004-2008.  The U.S. contributed significantly 
to the functional beverage industry’s total, accounting for $7.6 billion in revenue and a 
CAGR of 20.6%.  In addition, the U.S. energy drink industry is forecasted to more than 
double and reach an astounding $19.7 billion in 2013, which is almost a 160% increase 
from 2008 (Datamonitor, 2008).  Within the functional beverage category, the energy 
drink segment has seen the largest volume growth and increased annual sales both in the 
U.S. and abroad, taking in $4.8 billion in 2008 in the U.S. alone (Datamonitor, 2008).  
This increased growth can be attributed to more private label initiatives, larger container 
sizes, multi-pack options, sugar free versions, and juice hybrids that have a more 
palatable flavor (GMID, 2008; Canadean, 2009).  Currently, there are more than 300 
varieties of energy drinks from more than 200 brands in the U.S. alone all purporting to 
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increase energy, longevity and vitality in some form or another (Energyfiend, 2009).  
Although there is an abundance of energy drinks to choose from, the majority of the 
market share is comprised by only a handful of varieties, with Red Bull, Monster, 
Rockstar, Full Throttle, and Amp, with Red Bull accounting for 42% of the market share 
(Beverage Spectrum, 2008).  All in all, the energy drink industry has proven extremely 
profitable and is anticipated to continue with this same success in the years to come, and 
will be seen with new and innovative product launches reaching a more expanded market.  
          1.2 Target Demographic 
  Athletes were initially the primary consumers of energy drinks.  However, as 
the energy drink market has grown and expanded into various niche markets, athletes are 
no longer the primary target.  Today, the majority of energy drinks are targeted at teens 
and young adults 18-34 years old due to this generation’s on-the-go lifestyle and 
receptiveness to advertisements for these types of products (Lal, 2007).  The popularity 
of energy drinks among the younger generation is evidenced by 34% of 18 to 24-year-
olds being regular energy drink users (Mintel, 2009; O’Brien and others, 2008).  Another 
report found that about one-half of college students consume at least one energy drink per 
month in the hope to increase their energy level, to compensate for a lack of sleep or to 
mix with alcohol (Miller 2008).  The marketing and branding of many energy drinks 
reflects the market to which these companies are targeting.  A review presented at the 
2007 IFE Americas Food and Beverage Show confirmed that energy drink companies’ 
primary target market was adolescents and young adults (Agriculture and Agri-Food 
Canada, 2008).  Their appraisal stated that many of the energy drink companies were 
using cross-promotional tactics to reach their consumer base by integrating their product 
with extreme sporting events, such as the X-games or NASCAR, as well as advertising 
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their product in connection with popular music icons.  In addition to those tactics, energy 
drink companies have begun using creative, and in some cases defiant, names for their 
products to draw in consumers, with some examples being Full Throttle, Ammo, Havoc, 
Hydrive, Monster, and Morning Spark (Energyfiend, 2009).  The target market for energy 
drinks is broadening as new products are developed in an effort to reach niche sub-
markets and differentiate themselves from their competition.  Such sub-markets include 
energy drinks just for women, the carbohydrate-conscious, bodybuilders, or extreme 
sports enthusiasts.  In 2007, Del Monte Foods launched its first energy drink called 
Bloom Energy claiming that it was formulated specifically with women in mind.  Other 
energy drinks are targeted towards athletes such as Lucozade Sport and Revenge Sport 
which play up their advertised ability to increase physical performance and reduce fatigue 
in high-endurance sports.  The developers of Energy Fizz reached consumers through a 
different marketing approach, which was to promote their product’s convenience factor 
of being a powder that is packaged in a small portable tube that can be easily added to 
water on the go in order to get that needed energy boost.  Although on-the-go drink mixes 
are not new to the beverage industry as a whole, within the energy drink category they 
are.  Other energy drinks promote the unique qualities that make them stand out from the 
rest, such as being all natural, organic, or gluten free, as well as diabetic- or vegetarian-
friendly.  Energy drinks are still a developing industry in which a diverse range of new 
and innovative products will be seen in the years to come, with new innovations geared 
more towards the increasing number of health-conscious individuals. 
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1.3 Behavioral Impact of Energy Drink Consumption 
 
  There have been conflicting results concerning the effect of energy drinks on  
physiological and cognitive performance. Some studies have reported no significant 
difference in either the physiological or cognitive performance of individuals who have 
consumed energy drinks compared to those who have not (Carvajal-Sancho and 
Moncada-Jimenez, 2005; Umana-Alvarado and Moncada-Jimenez, 2004).  Research has 
been aimed at determining the behavioral effects of energy drinks on consumers; 
specifically, on their mood, concentration, reaction time, alertness, endurance, physical 
performance, and risk taking.  The cognitive and physiological effects after the 
consumption of an energy drink in comparison to a placebo resulted in significantly 
improved performance on both secondary memory and speed of attention (Scholey and 
Kennedy, 2004).  Another study looked at the effect Red Bull had on cognitive 
performance and well-being of the studied subjects, concluding that its consumption had 
a positive impact (Seidl and others, 2000; Alford and others, 2001).  Comparing the 
consumption of energy drinks to a placebo also revealed that energy drinks had an 
energizing effect, with the strongest effect observed 30 to 60 min after consumption, and 
the individuals having sustained energy for up to 90 min (Smit and others, 2004). The 
consumption of Red Bull also proved to be beneficial in improving aerobic endurance 
and anaerobic performance (Alford and others, 2001).  Another study showed that 
consuming an energy drink 40 min before exercise can improve endurance and physical 
performance (Ivy and others, 2009). Improvements in visual information processing, 
attention, and verbal reasoning have also resulted from the consumption of energy drinks 
(Warburton and others, 2001).  These responses are attainable from the consumption of 
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just one energy drink because research has shown that as little as 12.5 to 100 mg of 
caffeine can improve cognitive performance and mood (Smit and Rogers, 2000).  
Furthermore, a study looked at the effect an energy blend containing 80 mg caffeine, 
taurine, glucuronolactone, vitamins, and sugar on counteracting driver sleepiness and 
concluded that this blend was beneficial in reducing sleepiness and sleep-related driving 
incidents (Reyner and Horne, 2002).  There have also been several studies which have 
looked at the association between energy drink consumption and problem behavior. The 
results of a recent study concluded that increased energy drink consumption was 
associated with increased risk-taking behaviors (Miller, 2008).   
 Another common practice, especially among college students, is to mix alcohol 
with energy drinks (O’Brien and others, 2008).  It has been found that almost 25% of all 
college students who currently drink, mix alcohol with energy drinks (O’Brien and 
others, 2008).  The concept of alcoholic energy drinks has been a controversial issue in 
which the alcohol industry has received much criticism due to the dangers associated 
with this trend.  Several studies have shown that the consumption of energy drinks in 
combination with alcohol has resulted in a decreased level of perceived intoxication, 
which could result in an increased number of driving accidents or other alcohol-related 
incidents (Ferreira and others, 2006; Marczinski and Fillmore, 2006). The masking effect 
that energy drinks may have over alcohol intoxication is due to the combination of the 
stimulatory effect of caffeine and the depressant effect of alcohol on the body, hindering 
an individual’s true awareness of the typical signs of alcohol intoxication (eg. 
drowsiness) (Oteri and others, 2007).  However, one study found no significant 
differences among subjects who consumed alcohol in combination with energy drinks 
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and those who just consumed alcohol (Ferreira and others, 2004).  Further research is 
needed to better understand this association as well as increased awareness of the 
potential dangers that could result from the combination of alcohol and caffeinated 
beverages. 
1.4 Active Ingredients in Energy Drinks 
  Although there are hundreds of energy drinks out in the market, many share 
very similar ingredient profiles with the primary ingredient being caffeine.  Many of 
these unique energy blends consist of caffeine, taurine, and B vitamins, in various 
combinations, as well as at varying concentrations to act as the stimulants in those 
beverages.  Figure 1 depicts the chemical structures of the more widely used active 
ingredients found in mainstream energy drinks.  In addition to those stimulants, sugar is 
typically added, although many brands have sugar free options available as well. Other 
popular ingredients that are added to energy drinks are ginseng, guarana and yerba mate.  
The various ingredient combinations are critical because they are what give the beverage 
its distinct overall flavor, the amount of energy that will be produced, as well as the 
duration of that energy, and the various health properties of the beverage.   
Caffeine 
  The majority of energy drinks contain caffeine as an active ingredient due to its 
stimulatory effect on the central nervous system.  Caffeine’s main mechanism of action in 
concentrations typically achieved after the consumption of a caffeinated beverage is to 
act as an adenosine receptor blocker in the brain (Dunwiddie and Mansino, 2001; 
Pettenuzzo and others, 2008).  Caffeine has a similar chemical structure to that of 
adenosine, allowing caffeine to mimic adenosine and attach to the adenosine receptors.  
The blockage of adenosine to the neurons causes the sleep promoting effects of adenosine 
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Figure 1.  Chemical structures of active ingredients commonly found in energy drinks. 
(A) Major components of guarana: (a) caffeine, (b) theobromine and (c) theophylline; (B) 
B-vitamins (Helmenstine, 2009); (C) Taurine.  
Vitamin B-12 
a. b. c. 
Vitamin B-2 (riboflavin) 
Vitamin B-3 (niacin) 
Vitamin B-6 
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 to stop, resulting in the neurons speeding up instead of slowing down (Ferre, 2008).  
Caffeine is also known to increase the secretion of epinephrine, which can lead to a 
variety of secondary metabolic changes that can positively affect physical or mental 
performance (Graham, 2001).  Caffeine has been widely studied in a variety of areas 
regarding human health and performance, and it is evident that caffeine consumption can 
increase energy utilization (Smit and Rogers, 2002).  Several studies also confirm 
caffeine’s ability to enhance mood and alertness (Kaplan and others, 1997; Smit and 
Rogers, 2002; Lorist and Tops, 2003), exercise performance (Doherty and Smith, 2004; 
Graham, 2001), the speed at which information is processed, awareness, attention, and 
reaction time (Cysneiros and others, 2007).  Caffeine also has a stimulatory effect on 
thermogenesis (Acheson and others, 1980; Dulloo and others, 1989; Astrup and others, 
1990; Bracco and others, 1995).  In addition, caffeine consumption has also been linked 
to reduced food intake (Tremblay and others, 1988; Racotta and others, 1994; Lima and 
others, 2005) and to promote lipolysis in both animals and humans (Hasegawa and Mori, 
2000; Zheng and others, 2004; Kobayashi-Hattori and others, 2005; Lopez-Garcia and 
others, 2006). 
A research review regarding caffeine consumption concluded that among the 
healthy adult population, a moderate daily caffeine intake of ≤ 400 mg (equivalent to 6.5 
mg/kg bw/d for a 70-kg person) was not associated with any adverse effects (Nawrot and 
others, 2003).  These recommendations were based primarily on published human data 
obtained through a comprehensive literature search made on the basis of no adverse 
effects such as general toxicity, cardiovascular effects, effects on bone status and calcium 
balance (with consumption of adequate calcium), changes in adult behavior, increased 
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incidence of cancer and effects on male fertility (Nawrot and others 2003).  This review 
also concluded that pregnant woman should limit their caffeine intake to ≤ 300 mg/d 
(equivalent to 5 mg/kg bw/d for a 70 kg person) and children should consume ≤ 2.5 
mg/kg bw/d (Nawrot and tohers 2003).  In children, controlled clinical trials showed no 
adverse effects when consuming caffeine at levels up to 3 mg/kg bw/d (Higdon and Frei 
2006).  The exact amount of caffeine necessary to produce any adverse effects, such as 
sleeplessness, irritability, increased urination, abnormal heart rhythms or stomach upset, 
varies from person to person depending on their weight and sensitivity to caffeine 
(Higdon and Frei 2006).  Figure 2 shows a comparison of the amount of caffeine found 
in commonly consumed beverages, where it is apparent that the caffeine concentration of  
 
 
 
 
 
 
 
 
 
Figure 2. Caffeine (mg/8 oz) comparison in a variety of beverages 
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the average mainstream energy drink contains significantly less caffeine than the ≤ 400 
mg/d reported as the safe level (Nawrot and others, 2003).  The average caffeine 
concentration of an energy drink typically ranges from 80-140 mg/8 oz, well below this ≤ 
400 mg per day limit and is comparable to consuming 5 ounces of coffee or 2 cans of a 
caffeinated soft drink (Malinauskas and others, 2007).  However, it is important to be 
aware of the serving size since many of the 16-oz containers hold 2 servings.  Caffeine 
also has a diuretic effect regardless if its consumption is through an energy drink, tea, or 
coffee (Riesenhuber and others, 2006).  There are, however, several studies which 
conclude that caffeine consumption at physiologically relevant dosages (≤ 400 mg/d) 
does not cause diuresis (Falk and others, 1990; Scott and others, 2004; Armstrong and 
others, 2007).  Caffeine has a long history of safe use and overwhelming scientific 
evidence maintains that when consumed in moderation (300-600 mg/day/adult) no 
adverse effects should occur. Nonetheless, caution should be taken in regards to the 
amount of caffeine consumed per day.   
Taurine 
 
  Taurine (2-aminoethyl sulfonic acid) is a sulfur containing amino acid that is the 
most abundant amino acid found naturally in our bodies, primarily in the retina and 
skeletal and cardiac muscle tissue (Timbrell and others, 1995; Imagawa and others, 
2009).  Taurine is derived from the metabolism of methionine and cysteine (Huxtable, 
1992; Stipanuk, 2004).  It is also present in common food items such as meat and fish.  It 
has been estimated that the average daily human intake of taurine is between 40-400 mg, 
making taurine supplementation unnecessary unless a strict vegetarian diet is being 
followed with no meat or fish consumption (Shao and Hathcock, 2008).  The 
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incorporation of taurine into energy drinks and other products has increased a great deal 
over the past 10 years with taurine also being one of the most extensively used and 
studied amino acids (Shao and Hathcock, 2008).  However, when energy drinks launched 
between 2004 and 2008 were evaluated for the presence of taurine, a reduction in taurine 
was seen.  The results showed that one in four (27%) energy drinks in 2004 contained 
taurine, whereas in 2008 it was reduced to one in five (21%) (Mintel, 2009). 
  Taurine is associated with a variety of physiological functions including 
neuromodulation, cellular membrane stability, and modulation of intracellular calcium 
levels which has been seen both in vitro and in vivo (Huxtable, 1992; Timbrell and 
others, 1995).  Further research needs to be done on taurine to better explain the 
underlying mechanisms of action.  Furthermore, taurine has been seen to enhance 
endurance performance and to aid in the reduction of lactic acid buildup after exercise 
(Matsuzaki and others, 2002; Imagawa and others, 2009).   
 Once ingested, taurine experiences minimal metabolism in the body with 
taurine mainly undergoing conjugation to form bile salts as well as degradation to sulfate 
(Munro and Renwick, 2006).  The minimal metabolism of taurine allows for larger 
dietary intakes without any interference with the metabolism of other compounds in the 
body, and excess taurine is eliminated unchanged in the urine (Munro and Renwick, 
2006).   
The synthetic taurine that is present in energy drinks is found in very large 
concentrations. Taurine analysis of 80 different energy drinks showed an average 
concentration of 3180 mg/L which is equivalent to 753 mg/8 oz (Triebel and others, 
2007).  Several studies have determined the effect of taurine at various dosages ranging 
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from 375 mg/d to 8000 mg/d, concluding that there are no adverse effects (Mantovani 
and de Vivo, 1979; Kendler, 1989; Ikeda, 1997).  Other studies have also looked into the 
safety of taurine supplementation in humans and found no adverse effects (Sirdah and 
others, 2002; Brons and others, 2004; Zhang and others, 2004).  Although there has been 
no evidence showing taurine to cause any adverse health effects, concern has been raised 
since little research has been conducted on the effects of large quantities of taurine in 
combination with other ingredients commonly found in energy drinks such as caffeine.   
Guarana 
 
  Guarana comes from the Paullinia cupana plant, indigenous to South America.  
It originated in the Amazon basin in Brazil, where it has had a long history of use 
(Angelo and others, 2008).  It is commonly known for its small-berry like fruit it 
produces, which contains one to three dark seeds, accounting for the only edible part of 
the guarana plant (Scholey and Haskell, 2008).  The seeds contain a significant amount of 
caffeine, with 1 g guarana seed being equivalent to about 40 mg caffeine (Finnegan, 
2003).  Guarana contains other xanthine alkaloids specifically theobromine and 
theophylline, however, at much lower levels compared to caffeine (Weckerle and others, 
2003).  In addition to the caffeine content, guarana also contains relatively high amounts 
of saponins, flavonoids, and tannins, all contributing to the plants bioactive properties 
including its antioxidant activity (Espinola and others, 1997; Mattei and others, 1998).  
Guarana has become an increasingly common natural additive in energy drinks in recent 
years, largely for its stimulatory effect (Scholey and Haskell, 2008).  It has been stated 
that the caffeine from guarana is released at a slower rate compared to pure caffeine, 
giving off a more subtle and lengthier stimulatory effect (Scholey and Haskell, 2008).  It 
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is purported that this slower release is due to guarana being insoluble in water as well as 
containing tannins and saponins (Edwards and others, 2005).  There is however, no 
conclusive research that shows the caffeine release and absorption from guarana to be 
any different from that of pure caffeine (Bempong and Houghton, 1992).  Guarana has 
been suggested to improve cognitive performance, mental fatigue, and mood all at 
physiologically relevant dosages (≤ 400 mg/d), an effect supported by several research 
studies (Haskell and others, 2007; Kennedy and Haskell, 2008; Scholey and Haskell, 
2008).  Guarana has also been associated with inducing lipid metabolism, found to be due 
to its methylxanthine content (Lima and others, 2005).  Additionally, guarana has been 
shown to exert no toxic effects when consumed both in acute high dosages as well as in 
chronic lower dosages (Mattei and others, 1998). 
Ginseng 
 
The ginseng root has been used for over 2,000 years by many people in East 
Asian countries including China, Japan and Korea as a medicine for various diseases and 
for promoting longevity (Lee and others, 2005; Nam and others, 2005).  The ginseng 
plant is a small, shade-loving perennial shrub that reaches about 60 cm in height and 
belongs to the plant family Araliacae.  The market for ginseng products and ginseng-
related products has been estimated at $3.5 billion worldwide and is forecast to increase 
as a result of the increased research on the herb’s pharmacological effects (Hong and 
others, 2006).  There are several reported health benefits of ginseng which includes being 
an immune stimulant, producing improved physical and mental conditions, and having 
antistress, antiaging, antioxidant, and anti-inflammatory properties (Coon and Earnst, 
2002; Lu and others, 2009).  The pharmacological properties of ginseng are attributed to 
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its active constituents with ginsenosides being the most biologically active accounting for 
2-3% of ginseng (Okazaki and others, 2006; Lu and others, 2009).  Figure 3 shows the 
chemical structures of selected ginsenosides that were isolated from Panax ginseng (Kim 
and others, 2007).  Ginsenosides are secondary metabolites from ginseng root.  They are 
triterpene saponins and more than 40 of these compounds have been isolated and 
identified (Nah and others, 2007).  Each ginsenoside has its own unique structure, 
therefore, various pharmacological effects can result (Lu and others, 2009).  Many 
studies have investigated a single purified ginsenoside rather than analyzing a ginseng 
root extract in its entirety to determine and explain the various mechanisms of action of 
ginseng (Zhou and others, 2004; Cheng and others, 2005; Hofseth and Wargovich, 2007).  
Ginsenosides have been found to inhibit reactive oxygen species production, stimulate 
nitric oxide production, improve central nervous system function, and prevent 
cardiovascular and other diseases (Lu and others, 2009).   
In view of the increasing popularity of ginseng and its reported pharmacological 
effects, it is important to know whether or not there are any health risks for the 
consuming public.  Based on several studies conducted with animals and humans, 
ginseng is generally considered safe (Coon and Earnst, 2002).  However, the use of 
ginseng in very high doses has resulted in some side effects, which included 
hypertension, diarrhea, and sleep disturbances (Coon and Earnst, 2002).  Nevertheless, 
many other studies have claimed that, in comparison with other phytomedicines, ginseng 
has not been shown to produce serious side effects or dangerous interactions with other 
drugs (Nah and others, 2007). 
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Figure 3.  Chemical structures of selected ginsenosides isolated from Panax ginseng, an 
active ingredient commonly found in energy drinks. (Adapted from Kim and others, 
2007) 
20(S)-protopanaxadiol, where R1=R2=H 
 
20(S)-protopanaxadiol, where R1=R2=H 
 
RK1, where R1=glucose2-glucose 
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Yerba Mate 
  Yerba mate (Ilex paraguariensis) is native to South America where its main 
function is the production of yerba mate tea (Heck and de Mejia, 2007).  Yerba mate tea 
is a commonly consumed beverage in some South American countries and has been for 
centuries; however, it is increasing in popularity globally due to its content of a variety of 
bioactive components including polyphenols, xanthines, flavonoids, saponins, amino 
acids, minerals, and vitamins (Heck and de Mejia, 2007).  The abundant array of 
phytochemicals present in yerba mate has been connected to various health benefits. 
Yerba mate possesses anticancer, anti-inflammatory, and antidiabetic properties as well 
as acts as an inhibitor to oxidative stress (Heck and de Mejia, 2007; Markowicz-Bastos 
and others, 2007).  Moreover, yerba mate has shown to have high cytotoxicity to cancer 
cells and strong inhibition against topoisomerase II, which plays a role in cell division 
and therefore works to inhibit cancer cell proliferation (Heck and de Mejia, 2007).  Yerba 
mate also has a positive impact on the management of obesity, both in vivo and in vitro 
(Pang and Choi, 2008; Arcari and others, 2009; Martins and others, 2009).  The 
consumption of yerba mate significantly improved the serum lipid parameters in 
normolipidemic and dyslipidemic individuals (de Morais and others, 2009).  
Furthermore, yerba mate increased the degree of reduction in LDL-cholesterol levels in 
individuals who were also under statin therapy (de Morais and others, 2009).   
In addition, yerba mate is a central nervous system stimulant due to its high 
caffeine concentration, which is the primary reason for yerba mate to be incorporated into 
energy drink formulations. The caffeine concentration in 1 cup (8 oz) of yerba mate tea is 
equivalent to about 78 mg, which is approximately equal to the amount in an 8 oz Red 
Bull (80 mg) (Heck and de Mejia, 2007).   
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On the other hand, concerns have been raised regarding an association between 
yerba mate and the occurrence of certain types of cancer, specifically oral, esophageal, 
lung, bladder, and renal (Heck and de Mejia, 2007).  However, there is no conclusive 
evidence that this association is a result of the consumption of yerba mate, rather than due 
to various lifestyle choices including smoking and excessive alcohol consumption (Heck 
and de Mejia, 2007).  In addition, these cases have primarily been reported in areas of 
South America where large amounts of yerba mate are consumed at very hot and 
damaging temperatures which could lead to increased absorption of carcinogens that are 
found in cigarette smoke or other environmental pollutants (Heck and de Mejia, 2007). 
B Vitamins 
  B vitamins are a group of eight individual water-soluble vitamins, usually 
referred to as the B complex when grouped together, and all play essential roles in 
cellular processes.  B vitamins are incorporated into many of the mainstream energy 
drinks such as Red Bull where a can contains 360% of the recommended daily allowance 
(RDA) of B-6, 120% of B-12, and 120% of B-3.  The addition of excess amounts of B 
vitamins is also seen in the more extreme energy drinks like 5-Hour Energy shot which 
contains 8,333% of the RDA for vitamin B-12 and 2,000% of the RDA for B-6.  It is 
claimed that the consumption of these large amounts of B vitamins increases mental 
alertness and focus, as well as improve mood.    The average person, however, consumes 
the RDA of B vitamins from a typical diet since B vitamins are found in a variety of 
foods including bananas, lentils, potatoes, tuna, and turkey.  Vitamins B-2 (riboflavin), B-
3 (niacin), B-6 (pyridoxine, pyridoxal, pyridoxamine), and B-12 are the most common of 
the B vitamins that are incorporated into energy drink formulations.  Vitamin B-2 is a 
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coenzyme in the metabolism of carbohydrates.  Vitamin B-3 plays a major role as a 
coenzyme in energy metabolism, fat synthesis, and fat breakdown (Wardlaw and Smith, 
2009).  Vitamin B-6 is a group of 3 structurally similar compounds that all can be 
converted into the vitamin B-6 coenzyme which aids in the utilization of carbohydrates, 
fats, and proteins.  Vitamin B-12 assists in folate metabolism and in nerve function 
(Wardlaw and Smith, 2009).  Since all of the B vitamins are water-soluble, once the RDA 
has been met, the excess vitamins are excreted from the body via urine.  Although the 
consumption of a large amount of B vitamins does not possess any adverse health effects, 
the logic behind the extreme amounts of B vitamins in these beverages is not well 
rationalized.   
1.5 Beverage Health Functionality 
  In addition to the energy enhancing properties of the beverage products, many 
contain a variety of health promoting constituents including mainly antioxidants such as 
polyphenols.  Products high in antioxidants are important because they help protect the 
body’s cells from the damaging effects of free radicals which are known to damage 
proteins, lipids and DNA, reducing the risk of diseases such as cancer and coronary heart 
disease (Awika, 2003; Miller, 2006).  According to market research done by Mintel, 
about 60% of the U.S. respondents stated that they look for antioxidants when shopping 
for functional beverages, which definitely is an area in which energy drink companies 
could capitalize on (Lal, 2007).  Increasing the antioxidant and polyphenol content of 
energy drinks could be a key driver to increased sales and can be accomplished by 
incorporating yerba mate, green tea, ginseng or fruits such as pomegranate or the maqui 
and acaí  berry into the beverage formulation.   A future trend that could prove to be very 
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effective would be for energy drink companies to increase the functionality of their 
beverages to target the growing number of health conscious consumers (Lal, 2007).  
Areas in which these companies could expand could be vitamin and mineral fortification, 
organic options, all natural, no artificial flavors, preservatives or colors, weight control 
formulations, incorporation of fruit, as well as continuing with the low carbohydrate and 
low sugar options that are already highly visible in the market.   
1.6 Safety and Regulations 
  The regulation of energy drinks varies throughout the world with the U.S. 
having one of the more lax systems.  The U.S. Food and Drug Administration (FDA) 
code of federal regulations #21CFR-182.1180, lists caffeine, a main component in energy 
drinks, to have generally recognized as safe (GRAS) status which is a result of an 
overwhelming amount of scientific evidence concluding that when consumed in 
moderation (≤ 400 mg/d) caffeine has no adverse health effects.  The acute toxic level for 
the consumption of caffeine is not well established, but for adults it is approximately 10 
g/d, which is comparable to consuming approximately 100 cups of coffee per day, an 
excessive amount (Nawrot, 2003).  The FDA does regulate the caffeine content of cola 
drinks, allowing 0.02% of caffeine, totaling 71 mg for a 12 oz soft drink, to be added to 
those beverages; however that parameter does not cross over to energy drinks (U.S. code 
of federal regulations, #21CFR-182.1180).  In the U.S., energy drink companies have free 
reign over the caffeine content of their beverages because the FDA has placed no 
restrictions on an upper limit for caffeine.  Scientific as well as public concern has 
developed due to the increasing numbers of extreme energy drinks entering the market 
having caffeine concentrations well above those of mainstream energy drinks, which 
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contain on average 10 mg/oz.  Energy drink companies must however adhere to the 
federal regulations that have been put in place regarding proper labeling when it comes to 
caffeine.  Those regulations in the U.S. state that caffeine, along with any other 
ingredient, must be listed on the product label if added to the product as an ingredient.  
However, the amount of caffeine, or any other ingredient for that matter, does not need to 
be listed on the label leaving consumers in the dark in regards to actual amount they are 
consuming.  Efforts are being done to change this lack of regulation as discussed in the 
5th amino acid assessment workshop, giving priority to developing a safe upper limit for 
taurine due to the high concentration of taurine in many energy drinks (Munro, 2006).  
Many countries have addressed this concern and have developed regulatory guidelines 
for energy drink manufactures to follow.  The Australia New Zealand Food Authority 
(ANZFA) defined a distinct category of beverages called “formulated caffeinated 
beverages” which must contain no less than 145 mg/l and no more than 320 mg/l of 
caffeine, including “all caffeine present from whatever source”.  The European Union has 
not set an upper limit for caffeine however if the beverage contains greater than 150 mg/l, 
the product label must read “High Caffeine Content” followed by the amount of caffeine. 
An initial first step needs to be taken by the FDA in regards to the regulation of energy 
drinks, which could be as simple as requiring the manufacturer of these products to list 
the caffeine content as well as supply health warnings if their product contains caffeine in 
the amount of a specified upper level.  An increasingly diverse segment of the population 
is choosing to consume energy drinks amplifying the importance of implementing a 
formal regulatory plan for the production and sales of energy drinks. 
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2. Caffeine  
2.1 Sources 
  Caffeine is a naturally occurring alkaloid that is found in varying quantities in 
the beans, leaves, and fruits of more than 60 plants.  Some common sources of caffeine 
are the kola nut (Cola acuminate), cacao bean (Theobroma cacao), yerba mate (Ilex 
paraguariensis), and guarana berries (Paullinia cupana); however, roasted coffee beans 
(Coffea Arabica and Coffea robusta) and tea leaves (Camelia siniensis) are the world’s 
primary sources of dietary caffeine (Barone and others, 1996).  In the U.S., most of all 
dietary caffeine consumed is imported in the form of coffee and tea; cocoa, kola nuts and 
synthetic caffeine account for only a small portion (Bonita and others, 2007; Frary and 
others, 2008).  There is no chemical difference between synthetic caffeine and naturally 
sourced caffeine.  Caffeine is consumed most frequently in beverages such as coffee 
(71%), soft drinks (16%), and tea (12%) (Beverage Spectrum, 2008).   The market for 
caffeinated beverages has increased in the past decade with the introduction of functional 
beverages, including the energy drinks category, as well as other beverages such as 
caffeinated sport drinks, juices and waters (Beverage Spectrum, 2008).  In addition to 
these beverages, caffeine is also found in cocoa, chocolate, and in a variety of 
medications such as in some pain reliever formulations and in dietary supplements.  
2.2 Metabolism 
  Once ingested, caffeine is rapidly absorbed from the gastrointestinal tract into 
the bloodstream and becomes metabolized in the liver (Nawrot and others, 2003).  
Caffeine is extensively metabolized by the liver (99%) to form three major metabolites 
3,7-dimethylxanthine,1,7-dimethylxanthine and 1,3-dimethylxanthine showing that 70–
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100 mg of caffeine indicating a linear pharmacokinetics (Bonati and others, 1982).  For 
higher doses (250–500 mg), the clearance of caffeine is significantly reduced and its 
elimination half-life is prolonged, indicating non-linearity (Kaplan and others, 1997).  
Figure 4A shows an overview on how caffeine undergoes demethylation, resulting in 
paraxanthine (84%), theobromine (12%) and theophylline (4%), with the xanthenes 
theobromine and theophylline having very similar chemical structures compared to 
caffeine (Figure 4B) (Safranow and Machoy, 2005).  These metabolites are then broken 
down further in the liver by additional demethylations and oxidation to urates with about 
3% of those metabolites being caffeine when recovered in the urine (Mandel, 2002).  
Approximately 90% of the caffeine contained in one cup of coffee is cleared from the 
stomach within 20 min and peak plasma concentration is reached within approximately 1 
to 1.5 h (Chvasta and Cooke, 1971; Nawrot and others, 2003).  Once absorbed, caffeine 
exerts a variety of physiological actions to diverse organs of the body.  In doses typically 
contained in coffee, tea, and soft drinks caffeine’s main mechanism of action is to work 
as an adenosine receptor antagonist in the brain resulting in inhibitory effects to the 
central nervous system (Figure 5A and 5B) (Dunwiddie and Mansino, 2001; Pettenuzzo 
and others, 2008).  Since caffeine has a similar molecular structure to adenosine, with 
both having a comparable double bond ring structure, caffeine has the potential to occupy 
adenosine receptor sites, primarily A1 and A2a (Fisone and others, 2004).  The A1 
receptors are located in all parts of the brain with the heaviest concentration in the 
hippocampus, cerebral and cerebellar cortex and certain thalamic nuclei (Fredholm and 
others, 1999).  The A2a receptors are located in the dopamine rich areas of the brain 
(Fredholm and others, 1999).  After caffeine connects to those receptors an adenosine 
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Figure 4. Structure of caffeine and its metabolism (Taken from Safranow and Machoy, 
2005).   (A) Metabolism, (B) Chemical structures. Abbreviations: AFMU:  5-
acetylamino-6-formylamino-3-methyluracil; CYP 450:  Cytochrome P450; DMU:  
dimethyluric acid; DMX:  dimethylxanrthines; MUA:  monomethyluric acid; MX:  
monomethylxanthines; NAT 2:  N-acetyltransferase 2; TMU:  trimetylxanthines; TMX:  
trimethylxanthines; XO:  xanthine oxidoreductase. 
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Figure 5.  The mechanism of action of caffeine. (A) Normal action of adenosine; (B) 
Action of caffeine as an adenosine receptor antagonist. 
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blockage forms.  The blockage of adenosine to the neurons causes the sleep promoting 
effects of adenosine to stop, resulting in the neurons speeding up (Ferre, 2008). 
2.3 Caffeine Consumption and Human Health 
  Caffeine has been widely studied in a variety of areas regarding human health 
and performance (Smit and Rogers, 2002).  Many studies confirm caffeine’s ability to 
enhance mood and alertness (Kaplan and others, 1997; Lorist and Tops, 2003), exercise 
performance (Doherty and Smith, 2004), the speed at which information is processed, 
awareness, attention and reaction time (Cysneiros and others, 2007).  Although caffeine 
is being researched in a variety of areas regarding human health including Parkinson’s 
disease, skin cancer, and diabetes, the focus of this research was caffeine’s potential role 
as an aid in weight loss and weight maintenance.  Caffeine consumption, as contained in 
green tea, has been associated with weight reduction which demonstrates caffeine to be a 
potential tool for weight management through stimulating thermogenesis and fat 
oxidation (Kovacs and others, 2004; Westerterp-Plantenga and others, 2005).  
Additionally, caffeine supplementation has recently been considered as an effective 
means of weight management (Greenberg and others, 2006; Turk and others, 2009).  
Energy balance is the main determinant of weight regulation. In this context, research on 
caffeine has demonstrated its role in increasing metabolic rate, energy expenditure, lipid 
oxidation, and lipolytic and thermogenic activities; all favorable components in regards to 
weight management and possible weight loss in humans (Acheson and others, 2004; 
Ballard and others, 2006; Dallas and others, 2008).  Although the role of thermogenic 
activity in weight control is in the process of being analyzed, multiple studies have shown 
that caffeine can influence energy balance in humans.  In a recent investigation, the 24-h 
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increased energy expenditure from the caffeine consumption of 300 mg/d was found to 
be approximately 79 kcal/d, which may appear insignificant; however, it has been found 
to be sufficient in maintaining weight balance (Rudelle and others, 2007).  The American 
population has an average weight gain of approximately 1 kg/yr, equivalent to 15 kcal/d 
of excess energy (Hill and others, 2003).  It is also known that for 90% of the population, 
about 50 kcal/d are in excess of their daily energy expenditure (EE), which means that a 
50 kcal/d reduction could offset weight gain (Hill and others, 2003).  That being said, an 
increased EE of approximately 79 kcal/d can act as a positive contributor to maintaining, 
if not losing weight for active individuals (Rudelle and others, 2007).  One potential 
mechanism that could explain the thermogenic effect of caffeine is through the inhibition 
of cyclic AMP- phosphodiesterase (PDE) and the antagonizing adenosine receptors 
which negatively affect increased norepinephrine (NE) release (Westerterp-Plantenga and 
others, 2006).  The consumption of caffeine would consequently result in increased cyclic 
AMP, causing a heightened level of NE allowing the adrenoceptors to be continually 
stimulated (Dulloo and others, 1999; Dulloo and others, 2000).  However, the effect of 
caffeine on weight reduction should be interpreted with caution since for example, green 
tea drinking is effective only in individuals with originally low caffeine intake (< 300 
mg/day) (Kovacs and others, 2004).  Furthermore, in a long term observational study, 
caffeine intake was only associated with less weight gain (Lopez-Garcia and others, 
2006).  The use of caffeine to manage weight should consider the calorie contribution of 
the vehicle that contains caffeine and the potential negative effects of caffeine. 
3. Obesity and Weight Management 
Obesity is considered an epidemic of modern society and its prevalence  
30 
 
ontinues to increase, illustrating the importance for continued research in the area of 
obesity and weight management (Abelson and Kennedy, 2004).  The ultimate cause of 
obesity is a chronic imbalance between the kilocalories consumed and the kilocalories 
expended resulting in an increase in adipose tissue due to an increase in both adipose cell 
number and size (Stunkard, 1996).  In order to lose weight a negative kilocalorie balance 
needs to result and can be achieved by either decreasing intake or increasing expenditure.  
Figure 6 outlines adipogenesis, which is the process by which new fat cells develop from 
adipocyte precursor cells called preadipocytes which into mature adipocytes (Avram, 
2007).  The amount of adipose tissue can be regulated through the inhibition of 
adipogenesis and through reduced accumulation of fat (Rayalam and others, 2008).  
Adipogenesis involves two major events the recruitment and proliferation of 
preadipocytes followed by their subsequent differentiation into mature fat cells. Fat 
accumulation in adipose tissue can be decreased by reducing lipid uptake by adipocytes 
through the suppression of lipoprotein lipase (LPL) or reducing lipid synthesis through 
inhibiting fatty acid synthase (FAS) among other mechanisms (Jing-Jing and others, 
2008; Wang and Eckel, 2009). Increased research in the area of bioactive compounds and 
their potential role for the improvement of long term weight maintenance is needed.  
Weight loss is increasingly recognized to have major health benefits for overweight 
individuals as well as increase the life expectancy of those suffering from obesity-related 
health complications (Goldstein, 1992; Westerterp-Plantenga and others, 2005; Rayman 
and others, 2008).  It has been found that modest weight loss of just 5% to 10% of initial 
body weight can lead to beneficial health effects (Goldstein 1992; Wing and others, 1992; 
van Gaal and others, 1997).  Caffeine has been shown to have anti-obesity effects through 
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the suppression of body weight gain and adipose tissue formation (Diepvens and others, 
2007; Huang and others, 2009).  Additionally, caffeine has been reported to suppress 
body weight gain through stimulating thermogenesis, extending sympathetic stimulation, 
suppressing food intake and reducing adipose tissue mass (Dulloo and others, 1999, 
2000; Hasegawa and Mori, 2000; Zheng and others, 2004; Kazuo and others, 2005; 
Kobayashi-Hattori and others, 2005; Lopez-Garcia and others, 2006; Rashti and others, 
2009; Tanka and others, 2009).  Caffeine consumption could be an effective tool to 
increase the success rate of long-term weight maintenance and possible weight loss in 
humans.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6. Adipogenesis: The proliferation and differentiation process of preadipocytes 
into mature adipocytes. (Adapted from Avram and others, 2007) 
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III. RESEARCH SIGNIFICANCE 
  Unhealthy weight gain is a global health concern due to its many well-
recognized health implications.  With the incidence of obesity significantly increasing 
worldwide, research in the area of bioactive food components geared towards weight 
management would be very beneficial.   Since the energy drink market has seen 
impressive growth over the past decade and is expected to continue, it is a great avenue to 
develop and expand the health functionality of those beverages.  Given that synthetic 
caffeine is a prominent ingredient in energy drinks, and is also associated with body 
weight regulation and decreased lipid accumulation, makes it an ideal compound for 
further investigation.  Green coffee byproducts and the caffeine extracted from Yerba 
mate tea (matein) could be as effective as synthetic caffeine to inhibit in vitro lipid 
accumulation in adipocytes, making them a potential natural source, as well as an 
economical and environmentally sound alternative to synthetic caffeine for the 
incorporation into energy drink formulations. 
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IV. HYPOTHESIS AND OBJECTIVES 
1. Hypothesis 
 
• Yerba mate caffeine (matein) and caffeine from green coffee byproducts are 
as effective as synthetic caffeine in inhibiting in vitro adipogenesis and lipid 
accumulation and can be incorporated into energy drink formulations. 
 
2. Main Objective 
•  Develop a natural caffeine blend to replace synthetic caffeine in energy 
drinks with equivalent effectiveness to inhibit lipid accumulation. 
 
3. Specific Objectives 
 
• To determine caffeine concentration of matein and green coffee byproducts 
 
• To determine the lipid reduction potential of matein and green coffee 
byproducts in comparison to synthetic caffeine 
 
• To determine if a synergistic lipid inhibitory effect is present when a blend 
of matein and green coffee byproducts are used 
 
• To quantify the antioxidant capacity and polyphenol concentration in matein 
and green coffee byproducts  
 
• To develop a prototype energy drink formulation incorporating natural 
sources of caffeine and antioxidants 
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V. MATERIALS AND METHODS 
 
1.  Materials 
 
1.1  Chemical and Biological Materials 
Synthetic caffeine (SC) (99%), Isobutylmethylxanthine (IBMX), 
dexamethasone (DEX), insulin, 100 mM sodium pyruvate solution, penicillin (1000 
U/ml), streptomycin (1000 U/mL), Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid),  2,2-azobis 2-amidinopropane dihydrochloride (AAPH), formic acid 
(>95%), gallic acid (100%), HPLC grade methanol, Oil Red O dye, Orlistat, C75, 
butylated hydroxy toluene (BHT), epigallocatechin gallate (EGCG; ≥ 95% purity), and 
citric acid (99.5% purity) used in the prototype beverage formulation were purchased 
from Sigma-Aldrich (St. Louis, MO).  TIC Pretestol Ticalose CMC 2500 Fine Powder 
was the suspending agent used in the prototype beverage formulation and was provided 
by TIC Gums (Belcamp, MD).  Swiss albino mouse 3T3-L1 fibroblasts and Dulbecco’s 
modified Eagle’s medium (DMEM) were purchased from American Type Culture 
Collection (Manassas, VA). Cell Titer 96 Aqueous One Solution was purchased from 
Promega (Madison, WI) to determine cell viability.  Fetal bovine serum (FBS), calf 
bovine serum (CBS), Dulbecco’s phosphate buffered saline, diethylpyrocarbonate 
(DEPC) treated water, SYBR Green PCR Master Mix and trypsin-EDTA were 
purchased from Invitrogen (Grand Island, NY).  Fluorescein (3’,6’ dihydroxyspiro 
[isonezofuran-1[3H] 9’[9H]-xanthen]-3-one), HPLC grade water (99%), and Folin-
Ciocalteu’s phenol reagent (2 N) was purchased from Fisher Scientific (Hanover Park, 
IL).  RNeasy Lipid Tissue Mini Kit was purchased from Qiagen (Valencia, CA) to 
extract mRNA from adipocytes. Primers were purchased from Integrated DNA  
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Technologies (Coralville, IA).   
 
1.2 Natural Caffeine Sources and South American Berries 
 
The material which was studied included four green coffee byproducts from 
coffee processing (fractions GC1, GC2, GC3 and GC4) provided by a coffee 
manufacturing facility in Houston, Texas and the mate caffeine was extracted from 
Organic Guayaki Yerba Mate Tea, referred here as matein (MT) (Figure 7).   
 
 
 
 
 
 
 
 
Figure 7.  Visual representation of the four green coffee byproducts (GC1, GC2, GC3 
and GC4), matein (MT), and Yerba mate tea. 
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In addition to the natural caffeine blend, a variety of South American berries, including 
acaí, maqui, and mortiño berries were incorporated into a beverage formulation in order 
to increase consumer product appeal as well as to enhance the overall health functionality 
of the beverage.  Acaí (Euterpe oleracea) (Figure 8A), is a berry of the palm family, 
which has a long history of use due to its potential health benefits associated with the 
berries high antioxidant capacity and phytochemical composition (Schauss and others, 
2006).  The freeze dried acaí berry was donated by the Liotécnica Company located in 
Embu, São Paulo, Brazil.  Maqui (Aristotelia chilensis) (Figure 8B), is a shrub growing 
berry which has also a long history of use primarily in folk medicine to treat aliments 
such as sore throats, inflammation, diarrhea, lesions, and migraines (Schrekinger and 
others, 2010).  Maqui has been reported to have high concentrations of polyphenols, 
especially anthocyanins (Escribano-Bailon and others, 1990).  The maqui berries were 
collected in January 2009 from the Entrelagos region in Chile and were cleaned by 
removing leaves, stems and damaged berries. The whole berries were then freeze-dried, 
sealed in plastic bags, and shipped to our laboratory.  The mortiño berry (Vaccinium 
floribundum) (Figure 8C) is a shrub growing berry that is widely consumed in Ecuador 
as fresh fruit or as processed products and is known for their high phenolic content 
(Shreckinger and others, 2010).  Local communities have used the mortiño berry to treat 
inflammation and diabetes which can be attributed to their high phenolic content.  The 
mortiño berry is a natural product produced by the Simiatug Samai which is actually a 
commercially available product that was purchased from a local market in Quito, 
Ecuador.  This commercial powder was prepared by dehydrating the fresh berry at low 
temperatures (< 45 ºC) and high ventilation. 
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Figure 8. Visual representation of berries native to South America that were incorporated 
into the beverage formulation, (A) açaí (Euterpe oleracea), (B) maqui (Aristotelia 
chilensis), and (C) mortiño (Vaccinium floribundum); (Schrekinger and others, 2010).   
 
               Acaí berry                                       Acaí Palm                              Freeze dried acaí  
              Maqui berry                                       Maqui plant                        Freeze dried maqui 
            Mortiño berry                                  Mortiño plant                           Commercial mortiño  
                                                                                                                         
38 
 
1.3 Commercial Energy Drinks 
A variety of commercial products including 16 energy drinks and 15 ready to 
drink tea-based energy drinks, were purchased directly from several markets in 
Champaign, IL.  Product names are listed in the appendix. 
2. Methods 
2.1 Preparation of matein, green coffee byproducts and yerba mate tea 
Matein (MT) was obtained by supercritical CO2 extraction of mate tea leaves.  
The supercritical extraction apparatus was provided by the U.S. Department of 
Agriculture (Peoria, IL).  MT was extracted from organic mate tea using a water 
saturated CO2 supercritical extraction.  The temperature for the extraction vessel was   
70  C with a pressure of 398 bar.  The flow rate was 466 ml/min of liquid CO2.  A total 
of 1.5 kg of mate tea was placed in the supercritical CO2 extractor, and it took 
approximately 8 h for the entire procedure to be completed (Assis and others, 2006).  
The final product was freeze dried.   
The decaffeination process of raw green coffee at the processing plant resulted 
in 4 separate byproducts (GC1, GC2, GC3 and GC4), supplied by the coffee 
manufacturing facility, each containing different concentrations of residual caffeine.  
Green coffee byproduct 1 (GC1) was produced by the CO2 supercritical extraction 
technique; however, the second green coffee byproduct (GC2) was derived using water 
alcohol extraction.  Green coffee 3 (GC3) was a dried extract from a slurry known as 
liquid mother, a concentrated liquid extract effluent of  coffee processing and the fourth 
byproduct (GC4) consisted mainly of the fiber from the green coffee grain. The yerba 
mate tea brewing process was carried out following the protocol described by Chandra  
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Figure 9.  Schematic of the production of green coffee byproducts and matein. 
 
and Gonzalez de Mejia (2004).  Briefly mate tea (2.7 g) was mixed with 250 ml of 
boiling water at 98  C and held/stirred for 10 min.  The tea extract was filtered using 
Whatman paper #2 and lyophilized in a FreezeZone freeze dry system (Kansas City, 
MO) and stored at -20 C until the incorporation into the mate tea based energy drink 
prototype.   
2.2 Chemical Analysis 
2.2.1 Caffeine Quantification 
The caffeine concentration was quantified for the four green coffee byproducts 
(GC1, GC2, GC3 and GC4) and MT using high performance liquid chromatography 
(HPLC).  The quantification was carried out on an 1100 HPLC (Agilent Technologies, 
Santa Clara, CA) using a reversed phase Supelcosil-LC-18 column (250mm x 4.6mm x 
5μm) (Supelco, Bellefonte, PA).  Samples were dissolved at a concentration of 2 mg/ml 
and diluted down to a concentration of 0.1 mg/ml in 100% methanol and filtered through 
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0.22 μm filters.  Caffeine standards were prepared using commercially available pure 
caffeine (99.9%) at concentrations of 0.125, 0.25, 0.5, 0.75, 1.25 and 1.5 μg/ml and then 
filtered. The mobile phase consisted of 20% methanol, 0.3% formic acid and 79.7% 
water (A) and 0.3% formic acid in methanol (B).  The flow rate was held constant at 0.5 
ml/min with a step-wise gradient of 0%, 48% and 0% of solvent B at 52, 5 and 3 min, 
respectively.  The diode array detector was set for outputs of 280 and 330 nm.  The 
injection volume was 50 μL for the samples and 20 μL for the caffeine standards.  
Agilent’s Chemstation software was used for both protocol control and data processing.  
Caffeine concentrations in mg/ml was calculated from the caffeine standard curve (y = 
5216.4x – 29.02, R2 = 0.99). 
2.2.2 Elemental Mineral Analysis 
Elemental mineral analysis was performed after first digesting the samples with 
HNO3 in a PerkinElmer/Anton Paar Multiwave 3000 microwave digester, using a high 
pressure rotor.  The samples coming out of the digester were diluted to 50 ml.  The 
samples were analyzed using a PerkinElmer Elan DRCe Inductively Coupled Plasma 
(ICP) MS instrument (Norwalk, CT), in Total Quant (TQ) mode.  This method was 
reinforced through the use of a series of 50 ppb standards. The mineral concentration 
was expressed in ppm. 
2.2.3 Determination of Total Polyphenol Content  
 
Total phenolic content was measured using the Folin-Ciocalteu method, adapted 
to a micro-assay, from the method described by Chandra and de Mejia (2004).  Briefly, 
samples were prepared for the green coffee byproducts and matein by dissolving the 
powder in water and filtering with a 0.22 μM syringe filter; final concentration was 1 
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mg/ml.  To a 96-well flat bottom plate (Fisher 12-565-501), 50 μL of 1 N Folin-
Ciocalteu’s phenol reagent was added, then 50 μL of either sample, standard or blank 
were added; this mixture was allowed to stand for 5 min before the addition of 100 μL 
20% NaCO3.  The solution is then allowed to stand for 10 min and under the alkaline 
environment a reduction reaction takes places causing a shift in absorbance from yellow 
to blue, which is read at 690 nm in a fluorescent FLx800tbi Synergy 2 multi-well plate 
reader, (BioTek, Winooski, VT).  Gallic acid (GA) was used as a standard; with final 
concentrations of 10, 20, 30, 40, 50, 75 and 100 μg/ml.  Results were expressed as μg 
equivalents (eq.) GA, using the standard curve y = 0.027x – 0.106, R2 = 0.99.   
2.3 Antioxidant Capacity 
 
The ORAC assay was adapted from published methods (Davalos and others, 
2004; Prior and others, 2003).  Fluorescein and AAPH solutions were prepared using 75 
mM phosphate buffer, pH 7.4.  In triplicate (20 µL), samples GC1, GC2, GC3, GC4, 
MT, SC, EGCG, and BHT at concentrations ranging from 250 µM to 1000 µM, Trolox 
standard dissolved in 75 mM phosphate buffer at concentrations ranging from 4 µM to 
120 µM,  or 75 mM phosphate buffer blank were added to a 96-well black walled plate.  
After which, 120 µL Fluorescein was added and incubated for 15 min at 37˚ C.  After 
incubation 60 µL AAPH was added to a final concentration of 153 mM.  The 
fluorescence was read immediately in a fluorescent FLx800tbi Synergy 2 multi-well 
plate reader, (BioTek, Winooski, VT), at 37˚C, sensitivity 60, read every 2 min for 120 
min with excitation 485 and emission 528 nm.  Fluorescein reacts with the free radicals 
generated by the AAPH to produce a non-fluorescent product.  Loss of fluorescence is 
easured over time and the area under the curve is calculated with the following equation: 
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AUC = 0.5 + f1/f0 + fi/f0 + … + 0.5(fn/f0) 
Net AUC = AUCsample - AUCblank 
Where AUC is the area under the curve, f1 is fluorescence of first reading (2min), f0 is 
fluorescence of reading time zero and fn fluorescence readings.  Results were expressed 
as Trolox μM eq., using the standard curve y = 0.167 + 2.54, R2 = 0.99. 
2.4  Lipid Metabolism in 3T3-L1 Adipocytes 
 
2.4.1 Cell culture and treatments 
Figure 10 illustrates the process in which the 3T3-L1 preadipocytes underwent 
to develop into mature adipocytes.  First the 3T3-L1 preadipocytes were seeded at 3 x 
104 cells/cm2 in 24-well plates and cultured in DMEM containing 10 mM sodium 
pyruvate, 100 U/mL penicillin, 100 U/mL streptomycin and 10% FBS (FBS/DMEM).  
The preadipocyte differentiation was induced 3 days after reaching 100% confluency. 
The cells were stimulated with FBS/DMEM containing 167 nM insulin, 0.5 M IBMX 
and 1 M DEX for 2 days, followed by culturing with FBS/DMEM for an additional 4 
days, at which time 90% of cells were mature adipocytes with accumulated fat droplets.  
Mature adipocytes were treated separately at a non-cytotoxic concentration of 100 µM 
with SC, MT, GC1, GC2, GC3, GC4, MT/GC1 blend, EGCG, C75, and Orlistat with all 
samples dissolved in 0.2% dimethyl sulfoxide (DMSO), with the highest final 
concentration of DMSO used being 0.2%.  Furthermore, the cells were treated 
throughout the differentiation process on days 3, 5, 7 and 9 with 100 μM SC, MT, GC1, 
and a 50/50 blend of MT/GC1.  All treatments were compared to a negative control   
(untreated cells) and several positive controls including EGCG, Orlistat, and C75.  
Adipocytes were incubated at 37 ˚ C in a 5% CO2 atmosphere for 48 h before the lipid 
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 Figure 10.  Cell culture and treatment of 3T3-L1 adipocytes. Abbreviations: IBMX: 3-
isobutyl-1 methylxanthine; DEX: d examethasone; INS: insulin. 
 
 
  quantification was determined using the Oil Red O staining assay. 
2.4.2 3T3-L1 adipocytes cell viability assay 
The 3T3-L1 preadipocytes were seeded at 1.5 x 104 cells/cm2 in 96-well flat- 
bottom cell culture plates where they underwent differentiation and then were treated as 
indicated above.  Additionally, preadipocytes were also treated throughout the 
differentiation on days 3, 5, 7, and 9 to determine cytotoxic effects.  The CellTiter 
96Aqueous One Solution was used to determine the number of viable cells according to 
the manufacturer’s manual (Promega, Madison, WI).  Briefly, 20 μL of the CellTiter 
AQuaous One Solution was added to 100 μL of medium containing wells with cells, and 
then the plate was incubated in a 5% CO2 incubator at 37 ˚C.  After 2 h, absorbance was 
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measured at 515 nm with a 96-well plate reader (Biotek Instruments, Winooski, VT).  
Cell viability percentages were calculated using the following equation:  
(Atreatment, 515nm/Acontrol, 515nm ) * 100 = % cell viability. 
2.4.3  Lipid quantification in 3T3-L1 adipocytes using Oil Red O staining 
 
Intracellular lipid accumulation was determined by Oil Red O staining during 
adipocyte differentiation.  Throughout differentiation, adipocytes accumulate fat 
droplets and become spherical in shape.  Briefly, treated adipocytes were washed with 
Dulbecco’s phosphate buffered saline (DPBS) and fixed with 10% formalin (in DPBS) 
in 24-well plates for 1 h.  Then, cells were washed with 60% isopropanol and allowed to 
air dry.  The Oil Red O stock solution (0.1 g Oil Red O in 50 ml of 40% isopropanol) 
was added to lipid droplets for 1 h.  After Oil red O lipid staining, cells were washed 
four times with water to remove any excess stain and left to air dry.  Oil Red O dye was 
eluted by adding 100% isopropanol then incubating at room temperature for 10 min.   
OD510nm of eluted isopropanol was measured using a FLx800tbi Synergy 2 multi-well 
plate reader (BioTek, Winooski, VT).  Inhibition percentages of lipid accumulation were 
calculated using the following equation:   
  ((Acontrol, 510nm - Atreatment, 510nm)/Acontrol, 510nm ) * 100 = % inhibition of lipid content.  
2.4.4 RT-PCR analysis 
Total mRNA was extracted from matured 3T3-L1 adipocytes treated with 100 
μM SC, MT, GC1, MT/GC1 blend, EGCG, Orlistat and C75 using RNA easy mini-kit 
(Qiagen, Valencia, CA) according to the manufacturer’s instructions. RNA quality and 
concentration were determined by agarose gel electrophoresis and nanodrop 
spectrophotometry (ND-100 NanoDrop Tech, Wilmington, DE).  RNA expression of 
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target genes was measured using real-time quantitative PCR with SYBR Green 
fluorescence dye (Applied Biosystems, Foster City, CA).  Briefly, 2 µg purified RNA 
was reverse transcribed into complementary DNA.  Published primer sequences were 
used for LPL and FAS with 18S ribosomal RNA used as an internal control (Gonzales 
and Orlando, 2007; Koo and others, 2008).  The following primer sequences were used: 
LPL: forward 5’- CTGCTGGCGTAGCAGGAAGT-3’ 
          reverse 5’- GCTGGAAAGTGCCTCCATTG-3’ 
 
FAS:  forward 5’- TCGGCGAGTCTATGCCACTATT-3’ 
          reverse 5’- ACAGAGAACGGATGAGTTGTTCCT-3’ 
 
18S:  forward 5’- GATCCATTGGAGGGCAAGTCT-3’ 
         reverse 5’- AACTGCAGCAACTTTAATATACGCTATT-3’ 
 
 The plate was centrifuged with CR-422 centrifuge machine (Jouan, Inc., Frederick 
County, VA) and read with Taqman 7900 HT Real-time PCR System machine (Applied 
Biosystems, Foster City, CA).  The mRNA abundance relative to 18S was determined 
using comparative critical threshold method according to manufacturer’s instructions.     
2.5  Statistical Analysis 
Statistical analysis was performed using SAS version 3.1 (SAS Inst. Inc., Cary, 
NC).  The caffeine concentration, AC, TPC, and the in vitro lipid accumulation 
inhibition were evaluated by analysis of variance (ANOVA) using the proc GLM 
function for all treatments.  Statistical significance was identified with an alpha of 0.05 
and means comparison were made based on P-values obtained using Tukey’s HSD test.  
All analyses were based on at least 2 independent trials with 3 replicates per trial. 
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VI. RESULTS AND DISCUSSION 
 
1.  Chemical Analysis 
1.1  Determination of Caffeine Concentration 
Figure 11 depicts the caffeine concentration (%) present in MT and GC 
byproducts compared to SC (99.9%).  MT, GC1, and GC2 were found to have the highest 
caffeine concentrations with values of 91, 94, and 89% caffeine respectively (p < 0.05).  
GC3 and GC4 contained far less caffeine than expected, with values of 10% and 1% 
caffeine, respectively.  GC3 was a dried extract of liquid mother, a sludge that comes off 
of the decaffeination process of green coffee and GC4 is the byproduct from the outer 
shell of the green coffee bean containing over 20% fiber.  These results suggest that MT, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  Caffeine concentration (%) of MT, GC1, GC2, GC3, and GC4 compared to 
SC. Bars represent means ± standard deviation based on data from three independent 
experiments. Different letters indicate significant difference (p < 0.05). 
 
a 
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GC1, and GC2 would be excellent natural alternatives to SC in food and beverage 
applications. 
1.2  Elemental Mineral Analysis 
Table 1 shows the concentration of several nutritionally essential minerals that are 
present in MT and GC1.  MT and GC1 contained similar iron concentrations with 
reported values of 30.5 and 35.5 ppm, respectively.  GC1 was found to have higher 
concentrations of calcium, magnesium, and potassium, whereas MT was found to have 
higher concentrations of zinc.  It has been reported that the consumption of mate tea 
results in a more balanced and sustained energizing feeling compared to other caffeinated 
beverages.  This is thought to be due to a synergy between the caffeine and other 
chemical constituents present in mate tea, including their mineral contents.  
Unfortunately there has been no documented research that verifies this hypothesis. 
 
Table 1.  Mineral concentration present in MT and GC1. 
Mineral 
Mineral Concentration (ppm) 
MT GC1 
Calcium 19.4 105 
Chlorine 2620.4 1272.7 
Copper 1.8 0.4 
Iron 30.5 35.5 
Magnesium 8.9 25.7 
Manganese 0.3 0.5 
Potassium 30.1 280 
Sodium 59.1 1850.4 
Zinc 40.1 0.3 
ppm = parts per million (1 mg/kg = 1 ppm) 
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1.3 Total Polyphenol Content 
Figure 12 illustrates the total polyphenol content (TPC) of MT and the GC 
byproducts determined by the Folin-Ciocalteu method, using gallic acid (GA) as the 
standard.  SC was used as a negative control since it does not contain any phenolic 
compounds, however, due to its aromatic structure showed a background reaction with 
the Folin-Ciocalteu reagent.  GC3 (153.5 µg GA eq./mg ) and GC4 (64.3 µg GA eq./mg) 
resulted in the highest TPC compared to GC1, GC2, and MT.  These results were 
expected since GC3 and GC4 were found to have very low caffeine concentrations 
allowing for other components such as polyphenols to be more concentrated.  For a 
comparison, the TPC of mate tea (2.7 g in 250 ml), known for its numerous active 
phytochemicals among them being polyphenols, was also analyzed and resulted with 
 
 
Figure 12.  Total polyphenol concentration GC byproducts, MT, and SC expressed as µg 
equivalents of gallic acid. 
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213.6 µg GA eq./mg.  Among the samples which are comprised primarily of caffeine, 
MT (13.7 µg GA eq./mg) resulted with the highest TPC followed by GC1 (9.1 µg GA 
eq./mg), and lastly GC2 (6.5 µg GA eq./mg).   
2.  Antioxidant Capacity 
MT and GC byproducts are both known to contain high amounts of substances 
with health beneficial properties (Heck and de Mejia, 2007; Ramalakshmi and others, 
2009).  MT, GC byproducts, and SC were analyzed for their antioxidant content using the 
oxygen radical absorbance capacity (ORAC) assay, a widely used and preferred method 
due to its biological relevance to the in vivo antioxidant effectiveness (Prior and others, 
2003; Davalos and others, 2004). The ORAC method uses the peroxyl radical which is 
the most common free radical in the human body (Mermelstein, 2008).  Figure 13A 
shows the AC of GC3 and GC4 compared to EGCG, a natural compound widely reported 
for its extremely high AC (Seerman and others, 2006).  GC3 and GC4 were found to have 
a significantly lower AC compared to EGCG, however, still containing a substantial 
amount of antioxidants.  The AC of 1000 µM GC3 was 1550 ± 19 µM Trolox Eq. and 
GC4 had an AC of 553 ± 7 µM Trolox Eq.  Those byproducts contain minimal caffeine, 
however, could be utilized as a potent antioxidant contributor to a food product.  Figure 
13B depicts the AC of MT, GC1, GC2, MT/GC1 blend, and SC all compared to BHT a 
well known synthetic antioxidant.  MT (77 ± 3 µM Trolox eq.) was found to have similar 
AC as compared to BHT (71 ± 7 µM Trolox eq.), whereas GC1 had a lower AC of 34 ± 3 
µM Trolox eq. in an equimolar basis.  Although MT had a higher AC than GC1, when in 
combination the AC of 71 ± 0.3 µM was similar to MT alone.  SC was found to have no 
AC which is important because the replacement of SC with a blend of GC1 and MT 
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would increase the health functionality of food products while at the same time providing 
similar amounts of caffeine.  Compounds high in antioxidants are important because they 
help protect cells in the body from the damaging effects of free radicals known to damage 
proteins, lipids, and DNA, reducing the risk of diseases such as cancer and coronary heart 
disease (Awika and others, 2003; Miller and others, 2006).  These findings are promising 
in regards to the potential of MT and the GC byproducts being incorporated into beverage 
formulations as an alternative to SC.  In addition to the energy enhancing substances in 
energy drinks, mainly caffeine, many also contain a variety of health-promoting 
constituents, including antioxidants and polyphenols which are contributed by the various 
fruit or tea extracts that makeup those beverage formulations (Heckman and others, 
2010).  It was found that yerba mate tea-based energy drinks contained 100-fold higher 
amounts of antioxidants and polyphenols compared to the mainstream non tea-based 
energy drinks and the traditional brewed yerba mate tea (Heckman and others, 2010).  
The natural MT and GC byproducts would provide the desired stimulatory effect in 
addition to contributing to the overall health functionality of a food beverage product. 
3. Cell Culture 
 
3.1 Cell viability of 3T3-L1 adipocytes 
No effect on the viability of 3T3-L1 adipocytes was observed with any of the 
concentrations of MT, GC byproducts, SC, EGCG, C75, and Orlistat used in this study, 
indicating no cellular toxicity up to 200 µM for MT and the GC byproducts and 100 µM  
for SC, EGCG, C75, and Orlistat. 
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Figure 13.  Antioxidant Capacity of MT, GC1, GC2, GC3, GC4, and SC. (A) 
Antioxidant capacity of GC3 and GC4 compared to EGCG;  (B) Antioxidant capacity of 
GC1, GC2, MT, and SC compared to BHT. Bars represent means ± standard deviation 
based on data from three independent experiments. Different letters indicate significant 
difference among the samples at the same concentration. 
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3.2 Inhibitory effect of MT and GC byproducts on lipid accumulation in  3T3-L1      
adipocytes 
Figure 14 represents the percent inhibition of lipid accumulation by Oil Red O 
staining in completely differentiated 3T3-L1 mature adipocytes after 48 h of treatment 
with 100 µM MT, GC1, GC2, GC3, GC4, and SC relative to a negative control (untreated 
cells).  The cells were also treated with several positive controls including 100 µM C75 
and Orlistat, two well recognized anti-obesity drugs, as well as with100 µM EGCG, the 
most potent all natural anti-adipogenic compound (Kriedal and others, 2007; Moon and 
others, 2007; Mera and others, 2009; Thielecke and Boschmann, 2009).  Figure 14A 
shows that MT and GC1 had similar lipid inhibitory effect as SC, with MT showing the 
strongest effect of 18.4 ± 1.1%.  Furthermore, MT, GC1, and SC also had similar lipid 
reduction as compared to Orlistat (17.9 ± 1.1%) and EGCG (17.5 ± 0.6%).  GC2 showed 
significantly less inhibition with a 10.6 ± 1.2% reduction and GC3 and GC4 had 3.6 ± 0.4 
and 2.0 ± 1.2%, respectively.   
The inhibitory effect of these compounds on lipid accumulation in adipocytes 
was found to be highly correlated to their caffeine concentration (y = 5.979x - 4.073, R² = 
0.88); with MT and GC1 having the highest caffeine concentration of 90.8 and 93.8% as 
well as the highest lipid reduction.  These results are in agreement with previous research 
that concluded that caffeine suppressed the intracellular lipid accumulation after complete 
differentiation of 3T3-L1 adipocytes (Nakabayashi and others, 2008).  Additional studies 
have shown caffeine to exude anti-obesity properties through the reduction of adipose 
tissue weight in experimental animals (Bukowiecki and others, 1983; Michna and others, 
2003; Zheng and others, 2004).  Moreover, human studies have also shown caffeine to 
stimulate thermogenesis and the rate of fat oxidation (Dulloo and others, 1989; Astrup 
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and others, 1990; Bracco and others, 1995; Rumpler and others, 2001).  Caffeine 
supplementation has also been recently considered as an effective means of weight 
management (Greenberg and others, 2006; Turk and others, 2009).  Figure 14B depicts 
that an increased lipid inhibitory effect was present among GC1, MT, and SC after 
treatment throughout the differentiation process.   MT and GC1 resulted in an elevated 
inhibitory effect, with MT having 22.8 ± 2.2% and GC1 with 26.8 ± 1.8%.  GC1 had an 
8.6% and MT a 4.4% increased in lipid reduction compared to single treatment of mature 
adipocytes 48 h before Oil Red O staining.  GC1 was found to have similar lipid 
reduction compared to SC (29.3 ± 0.5%).  A significantly greater lipid reduction was seen 
among C75 (68.7 ± 1.0%), Orlistat (54.7 ± 1.7%), and EGCG (49.9 ± 3.5%) with all of 
their values significantly higher than MT, GC1, and SC (p < 0.05).  Previous research 
contradicts these findings, indicating that caffeine does not inhibit the differentiation of 
3T3-L1 pre-adipocytes to mature adipocytes (Nakabayashi and others, 2008).  Figure 15 
shows a visual of the Oil Red O stained adipocytes when treated at maturity, (A) control 
(untreated cells) compared to the 3T3-L1 adipocytes treated with (B) 100 µM MT which 
resulted in an 18.4% lipid reduction in both size and number, (C) 100 µM GC1 which 
showed a 17.1% reduction, and (D) 100 µM GC1 and MT blend with a 19.7% reduction. 
Figure 16A shows GC1 and MT in combination suppressed lipid accumulation in 3T3-
L1 cells in a dose dependent manner; however it did not show a synergistic, but rather, an 
additive effect.   The 10 µM 50/50 blend of MT and GC1 followed the same trend as the 
individual ingredients resulting in a more effective lipid inhibitory effect when treated 
throughout differentiation. However, 50 µM and 100 µM blends resulted in similar lipid  
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Figure 14. Inhibitory effect of lipid accumulation in 3T3-L1 mature adipocytes. (A) 
After 48 h treatment with MT, GC1, GC2, GC3, and GC4 GC1 in comparison to SC and 
several positive controls including C75, Orlistat, and EGCG. (B) After treatment 
throughout their differentiation on days 3, 5, 7, and 9 with MT and GC1 in comparison to 
SC and several positive controls including C75, Orlistat, and EGCG. Bars represent 
means ± standard deviation based on data from three independent experiments. Different 
letters indicate significant difference (p < 0.05).  
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Figure 15.  Oil Red O stained material of 3T3-L1 adipocytes treated with (A) control 
(untreated cells) compared to the reduction in lipids in 3T3-L1 adipocytes that were 
treated at maturity with (B) 100 µM MT, (C) 100 µM GC1, and (D) 100 µM GC1/MT 
blend. 
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Figure 16.  Inhibitory effect of lipid accumulation in 3T3-L1 adipocytes. (A) After 48 h 
treatment compared to treatment throughout differentiation on days 3, 5, 7, and 9 with a 
50/50 blend of MT and GC1. (B) After 48 h treatment with a variety of blend 
combinations of MT and GC1. Bars represent means ± standard deviation based on data 
from three independent experiments Different letters indicate significant difference (p < 
0.05). 
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reduction after single treatment as well as when treatedthroughout differentiation. The 
100 µM blend resulted in 19.7% ± 2.9 inhibition after single treatment and 22.2% ± 0.8% 
after treatment throughout differentiation.  These results were similar to the results of the 
individual compounds, concluding that when in combination there was not antagonistic 
effects.  Furthermore, Figure 16B depicts the lipid inhibitory effects in mature adipocytes 
after 48 h treatment with additional blend combinations of MT and GC1.  The largest 
lipid reduction was seen among the blends with the highest concentrations, MT and GC1 
blend 100/100 µM and 120/55 µM resulted in 22.4 ± 0.5% and 22.4 ± 0.8% inhibition, 
respectively.  The 55/55 µM blend had a lipid inhibitory effect of 19.4 ± 1.5% which was 
significantly comparable to the 55/120 µM blend with a 19.0 ± 1.0% inhibition.  
Additionally, the 55/55 µM blend had the same lipid reduction as the 10/100 µM.  These 
results suggest that at an equimolar concentration it does not matter which byproduct is 
more or less abundant because comparable lipid reductions will result.  Blend 
combinations of GC3 and MT were also investigated to determine whether or not a 
synergistic effect would occur as a result of the high polyphenol concentration and 
antioxidant capacity of GC3.  Figure 17 shows the lipid inhibitory effects seen in mature 
adipocytes after 48 h treatment of the GC3 and MT blend combinations. The GC3 and 
MT blend combinations did not result in a synergistic effect.  The blend combinations 
with higher concentrations of MT resulted in higher lipid reductions.  The sample which 
consisted of only 55 µM GC3 resulted in 0.78 ± 0.8% lipid inhibition, whereas the 55 µM 
MT resulted in 13.2 ± 0.9%.  The 55/55 µM blend of GC3 and MT showed a decreased 
lipid reduction compared to MT alone suggesting that when GC3 and MT are in 
combination a potential antagonistic effect is present.  The results from this study showed 
58 
 
that MT, GC1, and a MT/GC1 blend had a similar inhibitory effect as SC on the 
intracellular lipid accumulation in 3T3-L1 adipocytes suggesting that these compounds 
may play a role in lipid synthesis.   
3.3 Fatty Acid Synthase (FAS) and Lipoprotein Lipase (LPL) Gene Expression  
Figure 18 shows the effect that the caffeinated compounds had on FAS (A) and 
LPL (B) gene expression in 3T3-L1 adipocytes relative to the control (untreated cells).  
FAS and LPL activity were both decreased in 3T3-L1 cells treated with 100 µM SC, MT, 
and GC1 relative to control a 27.5, 29.4, and 40.9% reduction was seen for FAS  
 
   
Figure 17.  Inhibitory effect of lipid accumulation in 3T3-L1 adipocytes after 48 h 
treatment with a variety of blend combinations of GC3 and MT. Bars represent means ± 
standard deviation based on data from three independent experiments. Different letters 
indicate significant difference (p < 0.05). 
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Figure 18. mRNA abundance relative to control in 3T3-L1 mature adipocytes.  (A)  FAS 
expression inhibition; (B)  LPL expression inhibition. Bars represent means ± standard 
deviation based on data from three independent experiments. Different letters indicate 
significant difference (p < 0.05). 
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expression and a 51, 52.3, and 63.5% reduction was seen for LPL expression, 
respectively.  The results show that all of the tested products altered the gene expression 
of FAS and LPL, however no correlation was seen with regard to the Oil Red O staining 
results concluding that other mechanism of action are present.  FAS is an enzyme that 
catalyzes the synthesis of saturated fatty acids and it has been found that the suppression 
of FAS can lead to dramatic weight loss (Loftus and others, 2003; Schmid and others, 
2005).  Previous research in this laboratory has shown a down regulation of FAS in rats 
who consumed a high fat diet with the addition of SC and MT, resulting in suppressed 
weight gain, concluding that MT is a potential regulator of adipogenesis and lipid 
metabolism (Zapata, 2007).  Another study found FAS activity to be reduced in rats who 
consumed a coffee bean extract containing 10% caffeine which also resulted in a 
suppressed body weight gain compared to the rats fed the control diet containing none of 
the coffee bean extract (Tanka and others, 2009).  LPL is an enzyme that produces fatty 
acids which can be used for direct energy or can be stored as triglycerides in adipocytes 
(Jing-Jing and others, 2008).  The suppression of LPL activity in adipocytes can reduce 
the uptake of fatty acids resulting in less stored triglycerides. 
4. Results of Prototype  Development in Comparison to Commercial Energy 
Beverages 
 
MT and GC1 were found to be as effective as SC in in vitro lipid accumulation 
inhibition and would be a natural, economical, and environmentally sound alternative to 
SC for usage in beverage applications.   The energy drink market is embracing natural 
ingredients seen with many of the beverages incorporating yerba mate, green tea, 
ginseng, guarana, and a variety of fruits to only name a few.  Incorporating MT and GC1 
into a functional energy drink formulation that is geared towards weight management 
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would be ideal.  The beverage prototype concept was an on-the-go tea based energy mix 
that can be incorporated into bottled water for everyday convenience.  This beverage 
concept would be batch mixed and packaged in individual packets having a 24 month 
shelf life from date of manufacturing.  The beverage mix contains the blend of MT and 
GC1, formulated to contain 130 mg caffeine/500 ml, which is the typical water bottle 
size, as indicated in Table 2.  That caffeine concentration falls well below the 
recommended daily caffeine intake of ≤ 400 mg (equivalent to 6.5 mg/kg bw/d for a 70 
kg person) and is similar to an average 8 oz cup of coffee.  In addition to the natural 
caffeine blend, a variety of South American berries, including acaí, maqui and the 
mortiño berry were incorporated into the formulation to increase consumer product 
appeal as well as to enhance the overall health functionality of the beverage (Table 2).  
Figure 19 shows the AC and the TPC of acaí, maqui, and the commercial mortiño berry, 
with the maqui berry having the highest AC and TPC.  The acaí and maqui berries were 
both freeze dried, whereas the mortiño berry was commercially processed which may 
explain the lower AC and TPC of the mortiño berry compared the acaí and maqui. 
 
Table 2.  Ingredient composition of the prototype energy beverage  
Prototype
# 
mate tea 
(mg) 
MT 
(mg) 
GC1 
(mg) 
Acaí  
(mg) 
Mortiño 
(mg) 
Maqui 
(mg) 
AC 
(trolox 
µM eq.) 
 
TPC 
(GA µg 
eq.) 
 
1 1200 50 50 100 100 10 10888.8  2404.1  
2 1200 50 50 100 100 0 10433.7  2344 
3 1200 50 50 0 0 0 9574.1  1890.2  
4 1200 50 50 100 0 0 10225.7  2112.3  
5 1200 50 50 0 100 0 10081.2  2082 
*All beverages contained 0.25% cellulose gum 
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The availability and cost of these berries is a necessary component that needs to be taken 
into account when formulating.  Since a berry blend is being used, doing a cost 
comparison among the berries and incorporating more of the cheaper ingredient would be 
beneficial in order to minimize ingredient cost.  Yerba mate tea was selected to be used 
as the beverage base due to its high AC and TPC as depicted in Figure 20.   In addition 
to the mate tea, MT, GC1, and berry powders, a cellulose gum was added to the 
formulation to act as a suspending agent for the dry beverage mixture.  This gum is cold 
water soluble and was used at the recommended 0.25% usage level allowing the beverage 
mix to have an extremely rapid dissolution rate upon contact with water and only require 
a minimal amount of agitation.  The freeze dried mate tea, MT, and GC1 are water 
soluble; however the berry powders were not.  The gum allowed for consistent particle 
dispersion of the uniformed small particle sized berry powder to be maintained in a 
homogenous mixture when put into solution.  Table 2 lays out the ingredient composition 
of the prototype energy drinks that were developed.  All beverage prototypes included the 
same concentrations of freeze dried mate tea and the natural caffeine sources (MT and 
GC1), however, the berry combinations varied among the samples.  Prototype 1 included 
all 3 berries, where as prototype 2 included the acaí and mortiño, and prototype 3 
included none of the berries. Beverage prototype 4 included only the acaí berry and 
prototype 5 included just the mortiño berry.  The 1.2 g freeze dried mate is equivalent to 
5 g of dry mate prepared in 500 ml water, a typical North American usage level.   The 
maqui berry was used at a lower concentration compared to the acaí and mortiño berry 
because it is a potent natural colorant.  The maqui and acaí did not contribute to the 
beverages overall color therefore prototype 4 and 5 which did not include the maqui  
63 
 
 
 
 
Figure 19.  Antioxidant capacity and total polyphenol concentration among the berry 
samples used in the energy drink formulation. 
 
 
 
 
 
   
 
 
Figure 20.  Antioxidant capacity and total polyphenol concentration is 100 fold higher in 
yerba mate tea based beverages compared to mainstream energy drinks. * The traditional 
yerba mate tea was prepared by mixing 10 g of tea with 1 L boiling water at 98˚ C and 
held/stirred for 10 min then filtered (Chandra and Gonzalez de Mejia, 2004).   
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would not be visually acceptable products.  After these prototype mixtures were added to 
500 ml of water the powder rapidly went into solution and a deep blue color resulted due 
to the anthocyanins present in the berries.  Prototype 1, 2, and 3 were also formulated to 
include 20 mg citric acid which converted the beverage color to a deep red/purple.  
Figure 21 shows a visual representation of the 3 beverage prototypes (1, 2, and 3) in 
which (A) represents the beverages with citric acid (B) without citric acid, and (C) a 
close up of the most visually appealing and marketable beverage (prototype 1A) in which 
further analysis was conducted to determine its AC and TPC.  Among all of the samples 
it is apparent that maqui is the only berry that delivers any significant color to the 
beverage, since maqui was only included in prototype 1 and was the only beverage which 
displayed a visually pleasant color.  After the initial prototype was developed which 
consisted of the freeze dried mate tea, MT, GC1, acaí, mortiño, maqui, citric acid, and 
cellulose gum it was analyzed for its AC and TPC and compared to commercialized 
mainstream energy drinks.  Several mainstream energy drinks, 16 non tea-based and 15 
tea-based, were analyzed for their antioxidant content using the oxygen radical 
absorbance capacity (ORAC) assay.   Our data resulted in an AC range among the non 
tea-based beverages of 286.3 ± 63.9 to 3393.2 ± 106.1 µM Trolox eq., with an average of 
1275.4 µM Trolox eq.  The tea-based energy drinks had much higher antioxidant 
capacities with a range of 1749.8 ± 212.7 to 45824.2 ± 1430.6 µM Trolox eq., with an 
average of 10597.9 µM Trolox eq.  The AC for the prototype beverage was 10888.8 ± 
263.4 µM Trolox eq., which is significantly higher compared to all of the mainstream 
energy drinks that were analyzed.   The TPC was measured in the same energy drinks 
with the Folin-Ciocalteu method.  The TPC among the non tea-based beverages ranged  
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Figure 21. Visual representation of the beverage prototypes 1-3.  All beverages contained 
1.2 g mate tea and 50 mg of both MT and GC1, however, the berry combinations varied. 
Beverage 1 contained acaí, maqui and mortiño; beverage 2 contained only the acaí and 
mortiño; beverage 3 contained no berries; (A) with citric acid and (B) without citric acid 
and (C) a close up of beverage prototype 1A. 
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from 309.4 ± 1.3 to 1497.5 ± 68.5 µg GA eq. with an average of 673.2 µg GA eq.  The 
tea-based beverages had a range of 496.1± 66.3 to 43010.2 ± 18.9 µM GA eq., with an 
average of 1318.7 µM GA eq.   The TPC for the prototype beverage was 2404.9 ± 38.91 
µM GA eq., which was significantly higher compared to the mainstream energy drinks 
that were analyzed.   Figure 22 shows a comparison of the AC among the (A) 
mainstream energy drinks and (B) tea based energy drinks compared to the beverage 
prototype.  Figure 23 shows a comparison of the TPC among the (A) mainstream energy 
drinks and (B) tea based energy drinks compared to the beverage prototype.  The AC and 
TPC values for the prototype beverage can be increased if higher concentrations of the 
mate, natural caffeine sources, or berries are used; however, from a cost perspective 
increasing the levels might not be ideal. 
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Figure 22.  The antioxidant capacity of (A) mainstream energy drinks and (B) tea based 
beverages compared to the developed beverage prototype. 
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Figure 23.  The total polyphenol concentration of (A) mainstream energy drinks and (B) 
tea based beverages compared to the developed beverage prototype. 
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VII. SUMMARY AND INTEGRATION 
The prevalence of obesity is increasing worldwide fueling the need for the 
development of functional beverages geared towards weight management.  With the 
energy drink market growing at an exponential rate, improving the health functionality 
within that beverage category would be ideal.  Caffeine inhibits the lipid accumulation in 
adipocytes, thus contributing to preventing obesity.  Replacing synthetic caffeine (SC) 
with natural sources like matein (MT) and green coffee (GC) byproducts could aid 
towards having more health focused products.  Additionally, increasing the antioxidant 
and polyphenol contents of energy drinks would enhance the beverages overall health 
properties which can be accomplished by incorporating ingredients like Yerba mate and 
fruits such as the acaí and maqui berry.  The increased health functionality of these 
beverages will benefit the consumer as well as potentially prove to be key drivers for 
increased sales. 
The results from this study suggest that MT and GC1 will promote weight 
management through the regulation of adipogenesis and lipid accumulation, in a similar 
manner to SC.  The incorporation of MT and GC1 into food or beverage products could 
potentially decrease adipocyte accumulation and might prove to be a very effective 
approach for improving long term weight maintenance.  However, the clinical 
significance of these in vitro results needs to be validated in vivo.   
In addition to the lipid reduction, MT and GC1 have a similar AC compared to 
BHT, a known antioxidant, whereas SC was found to have none.  Furthermore, the total 
polyphenol content (TPC) was determined, and GC1 had a TPC of 9.1 µg GA eq./mg and 
MT  13.7 µg GA eq./mg, which was over twice as high as SC (5.7 µg GA eq./mg).   
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These results show great promise for MT and GC1 to be natural alternatives to SC and 
their incorporation into beverage applications could enhance the products overall health 
functionality.   
A prototype on-the-go tea-based energy drink mix was developed for the 
incorporation into bottled water which incorporated freeze dried Yerba mate tea, MT and 
GC1 into the product formulation.  The energy drink formulation contained 130 mg 
caffeine/500 ml, in line with other commercial caffeinated beverages.  Additionally, a 
blend of berries native to South America were incorporated into the beverage mixture 
which included acaí, maqui and mortiño berries.  The berry inclusion improved the AC 
and TPC of the beverage, proved to be a natural colorant, and enhanced the overall 
product appeal.  The prototype was found to have significantly higher concentrations of 
both antioxidants and polyphenols compared to mainstream energy drinks and aligned 
with commercially available tea-based energy drinks.    
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VIII. CONCLUSIONS 
• GC1 and MT were found to have the highest caffeine concentration with values of 
94% and 91%, respectively, making them natural alternatives to SC in food and 
beverage applications. 
 
• GC1 had a TPC of 9.1 µg GA eq./mg and MT was 13.7 µg GA eq./mg; over twice 
as high as SC (5.7 µg GA eq./mg).    
 
• GC3 had the highest TPC of 153.5 µg GA eq./mg and AC of 1550 ± 19 µM Trolox 
eq. 
 
• The AC of MT (77 ± 3 µM Trolox eq.) was similar to BHT (71 ± 7 µM Trolox Eq.), 
a known antioxidant, and GC1 had a reported AC of 34 ± 3 µM Trolox Eq. in an 
equimolar basis, and SC was found to have no AC. 
 
• The inhibitory effect that MT and the GC byproducts on the lipid accumulation in 
adipocytes was found to be highly correlated to their caffeine concentration (y = 
5.979x - 4.073, R² = 0.88) 
 
• 100 µM of MT and GC1 resulted in a similar lipid inhibitory effect when 3T3-L1 
adipocytes were treated at maturity compared to SC, Orlistat, and EGCG; with MT 
showing the strongest effect of 18.4 ± 1.1%.   
 
• An increased lipid inhibitory effect was present among GC1, MT, and SC after 
treatment throughout the differentiation process.   MT and GC1 resulted in an 
elevated inhibitory effect, with MT having 22.8 ± 2.2% and GC1 with 26.8 ± 1.8%. 
 
• GC1 and MT in combination suppressed lipid accumulation in 3T3-L1 cells in a 
dose dependent manner; however it did not show a synergistic but rather an additive 
effect.    
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• The results from this study showed that MT, GC1, and a MT/GC1 blend had a 
similar inhibitory effect as SC on the intracellular lipid accumulation in 3T3-L1 
adipocytes suggesting that these compounds may play a role in lipid synthesis.   
 
• FAS and LPL activity were both decreased in 3T3-L1 cells treated with 100 µM 
SC, MT, and GC1 relative to control; however no correlation was seen with regard 
to the Oil Red O staining results concluding that other mechanisms of action are 
present. 
 
• The AC for the prototype beverage which incorporated MT and GC1 was 10888.8 ± 
263.4 µM Trolox eq. and the TPC was 2404.9 ± 38.91 µg GA eq., which were both 
significantly higher than the mainstream energy drinks that were analyzed. 
 
• Commercial mainstream energy drinks averaged 1275.4 µM Trolox eq. (ranged 
286.3 ± 63.9 to 3393.2 ± 22.5 µM Trolox eq.) and TPC average was 673.2 µM GA 
eq. (ranged 309.4 ± 1.3 to 1497.5 ± 68.5 µM eq. GA).   
 
• Commercial tea-based energy drinks averaged 8081.7 µM Trolox eq. (ranged 
1749.8 ± 212.6 to 22735.6 ± 618.2 µM Trolox eq.) and TPC average was 1105.0 
µM GA eq. (ranged 496.1 ± 66.3 to 3774.9 ± 14.2 µM eq. GA).   
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IX. FUTURE STUDIES 
 
 
Future in vivo studies are necessary in order to validate the efficacy of MT and 
GC1 for its potential contribution in weight management through inhibiting adipogenesis 
and lipid accumulation as were seen in this study in an in vitro 3T3-L1 cell model.  After 
validation has been reached, progression towards implementing these ingredients into a 
functional energy drink beverage application can be carried out. Through this current 
research a beverage prototype was developed setting the foundation for future studies 
necessary for product commercialization.  The prototype encompasses the MT and GC1, 
freeze dried Yerba mate tea, a blend of berries, including the acaí, mortiño, and maqui 
and the appropriate concentrations of citric acid and gums to establish a powder mix that 
can be added to a water bottle that rapidly goes into solution and stays suspended.  
Although this drink mix provides 130 mg of natural caffeine and a berry blend that 
contributes the overall health composition of the beverage, as well as acts as a natural 
colorant, further research in regards to the sensory characteristics of this beverage needs 
to be completed.  Future sensory evaluations are needed to determine the consumer 
acceptability of this product as well as to work on flavor enhancement.  Additional 
flavorings or sweeteners may be necessary to mask potential bitter notes contributed by 
the caffeine, as well as to make the beverage more acceptable to the end consumer.   
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APPENDIX A 
 
 
 
 
 
 
 
 
 
 
 
 
       
HPLC profile of caffeine in matein, green coffee 1 (GC 1), green coffee 2 (GC 2), green 
coffee 3 (GC 3) and green coffee 4 (GC4) (synthetic caffeine standard curve: y = 5216.4x 
– 29.021 R2 = 0.99); abbreviations: GC1: green coffee byproduct 1; GC2: green coffee 
byproduct 2; GC3: green coffee byproduct 3; GC4: green coffee byproduct 4; MT: 
matein. 
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APPENDIX B 
 
 
 
Standard curve of synthetic caffeine at concentrations of 0.125, 0.25, 0.5, 0.75, 1.25 and 
1.5 µg after HPLC analysis. 
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APPENDIX C 
 
      
Standard curve of gallic acid at concentrations of 0.125, 0.25, 0.5, 0.75, 1.25 and 1.5 µg 
used for the determination of total polyphenol content. 
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APPENDIX D 
 
     
 
Standard curve of Trolox, a known antioxidant, at concentrations of 4, 8, 12, 24, 48 and 
60 µM used for the determination of antioxidant capacity. 
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APPENDIX E 
 
 
 
Figure of the fluorescence degradation of the top 5 mainstream energy drinks in the U.S. 
market compared to the control blank verse time. 
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APPENDIX F 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Dissociation curves of 18S (A) and Fatty Acid Synthase (FAS) (B) mRNA in 3T3-L1 
adipocytes   
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APPENDIX G 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissociation curves of 18S (A) and Lipoprotein Lipase (LPL) (B) mRNA in 3T3-L1 
adipocytes 
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APPENDIX H 
 
Mainstream energy drinks 
24-7 
Amp 
Full Throttle 
Gazzu 
Hydrive 
Jolt 
Lost 
Monster 
No Fear 
NOS 
Red Bull 
Rockstar 
Rockstar Juiced 
SoBe 
Unbound 
Venom 
 
Tea-based energy drinks 
Amazon Energy 
Bolthouse Farms Chai Tea 
Fuze White Tea 
Gold Peak Tea-unsweetened 
Guayaki Yerba Mate energy 
drink 
Honest Jasmine Green Tea 
Lipton Pure Leaf Iced Tea 
Luzianne Iced Tea 
Nestea Iced Tea 
Oi Ocha Dark Green Tea 
Snapple Green Tea 
Sobe Green Tea 
Teas' Tea Green White 
Tradewind’s Sweet Tea 
Tradewind’s unsweet Tea 
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